WHY INVEST IN DRAGON JADE (OTCBB: DGJI)?
It becomes abundantly clear that traditional Chinese medicines (TCM) is going to be the next modality and prescribed TCM formulas will be viewed as powerful therapeutic cures. Dragon Jade pioneering endeavors in promoting better access and broader use of TCM will definitely be paid off and return of investments should be remarkable.
Dragon Jade in-depth understanding of how to carry out biomedical experimentation, clinical traits, systematic reviews and sampled surveys will surely help its selected traditional Chinese medicines partner companies to meet the western scientific disciplines of medicines or healthcare products.
Dragon Jade has extensive know- how techniques to implement and comply with the prescribed codes of practices and relevant laws and ordinances. These merits will definitely attract generous funds and revenues in the near future for there are far too many TCM companies are eager to seek assistance to help them deal with the tough FDA regulatory regime.
Exclusive Distribution Right of Huang Fei Hong Products
Alpha Ultimate Limited, a wholly owned subsidiary of Dragon Jade International Limited, announced today that an exclusive
distribution agreement was entered into by and between Alpha Ultimate Limited, on the one hand, Huang Fei Hong
Pharmaceutical International Company Limited (“Huang Fei Hong”), on the other
hand (the “Distribution Agreement”).
Huang Fei Hong develops and manufactures health and nutritional herbal
products, which include herbal oil, pain relief plaster and healing wine (the
“Huang Fei Hong Products”). Pursuant to
the Distribution Agreement, Huang Fei Hong granted to Alpha Ultimate Limited
the exclusive right to promote and distribute the Huang Fei Hong Products in
Hong Kong and Taiwan for a period of 10 years.